1 of 1
Story summary
- Johnson & Johnson reached an agreement with the U.S. President Donald Trump to reduce drug prices in exchange for tariff exemptions.
- The deal follows similar agreements with nine other pharmaceutical companies.
- Johnson & Johnson will participate in the TrumpRx.gov site for discounted drug purchases and provide Medicaid access at competitive prices.
- The plan includes two new manufacturing facilities in North Carolina and Pennsylvania as part of a $55 billion investment.
